Leef Brands (LEEEF) Income from Continuing Operations (2025 - 2026)

Leef Brands' (LEEEF) quarterly Income from Continuing Operations came in at 426253.0 in Q1 2026, down 260.38% year-on-year from 265776.0 in Q1 2025, and down 260.38% quarter-over-quarter from 265776.0 in Q1 2025.

Leef Brands (LEEEF) Income from Continuing Operations (2025 - 2026) Analysis & Trends

Leef Brands has disclosed Income from Continuing Operations across 2 years of filings, most recently posting 426253.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Leef Brands - - 4.62 Mn -426,253.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -426,253.00
Mar 31, 2025 265,776.00